Menarini Silicon Biosystems announces publication of the DETECT III trial results highlighting the potential clinical utility of HER2 testing in circulating tumor cells with CELLSEARCH ...Middle East

Results published by the DETECT study group indicate the relevance of assessing biomarker expression in Circulating Tumor Cells (CTCs) with the minimally invasive liquid biopsy-based CELLSEARCH® platform to optimize treatment strategy and outcome in patients at an advanced stage of their...

Hence then, the article about menarini silicon biosystems announces publication of the detect iii trial results highlighting the potential clinical utility of her2 testing in circulating tumor cells with cellsearch was published today ( Tuesday 09/01/2024 - 01:44 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Menarini Silicon Biosystems announces publication of the DETECT III trial results highlighting the potential clinical utility of HER2 testing in circulating tumor cells with CELLSEARCH )

Also on site :

• Ukraine-Russia war latest: Xi reportedly told Trump that Putin might ‘regret’ invading Ukraine
• Un estudio señala que las demoras en Lima durante las elecciones no habrían afectado el resultado en Perú
• Iran wants to hand over nuclear stockpile to Russia – media